| Ticker: | CSGBX |
| Manager: | Andrew Thut |
| Manager Since: | 03/04 |
| NAV (05/17/2013): | 20.36 |
| Objective: | Equity - Small Cap |
| Peer: | SC SG |
| Net Assets ($mil): | 1.51 |
| Inception: | 09/14/1993 |
CSGBX : Description
Incepted in September 1993, the fund is managed by BlackRock Advisors. The fund seeks long-term capital appreciation. The fund invests at least 80% of its net assets in equity securities issued by U.S. small capitalization growth companies (market capitalization under $2.5 billion). The management team expects these companies to have products, technologies, management, markets and opportunities which will facilitate earnings growth over time that is well above the growth rate of the overall economy and the rate of inflation. The fund offers dividends on a quarterly basis and capital gains annually.
CSGBX : Composition - 05/13
| Stocks | 99.35% |
| Foreign Stocks | 7.07% |
| Cash | 16.94% |
| Bonds | 0.00% |
| Foreign Bonds | 0.00% |
| Preferred | 0.00% |
| Convertible | 0.00% |
| Other | -16.29% |
| Foreign Hedged | 0.00% |
CSGBX : Style Analysis - 05/13
| Large Growth | 9.94% |
| Large Value | 0.00% |
| Small Growth | 75.64% |
| Small Value | 0.00% |
| Foreign Stock | 9.94% |
| Emerging Market | 0.00% |
| Precious Metals | 0.00% |
| Intermediate Bond | 0.00% |
| High Yield Bond | 0.00% |
| Foreign Bond | 0.00% |
CSGBX : Risk Analysis
| Beta v. S&P 500 | 1.24 |
| Beta v. EAFE | 0.02 |
| Beta v. Barclays Agg Bond | -1.56 |
| Alpha 3 Yr | -6.82 |
| Alpha 5 Yr | -1.15 |
| R-Sq 3 Yr | 0.87 |
| R-Sq 5 Yr | 0.84 |
| Std Dev 3 Yr | 22.24 |
| Std Dev 5 Yr | 25.26 |
| Sharpe 3 Yr | 0.52 |
| Sharpe 5 Yr | 0.29 |
CSGBX : Fees
| Expense Ratio | 2.07 |
| % Max Load | NA |
| % Min Load | 0.00 |
| % Deferred Load | 4.50 |
| % Redemption | NA |
| % Max 12 B1 Fee | 1.00 |
| % Max Mgt Fee | 0.54 |
CSGBX : Purchase Choices:
| Min Initial Investment | 0 |
| Min Subsequent Investment | 0 |
CSGBX : Returns Analysis - Annual
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | YTD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAV ($) | 12.84 | 14.03 | 14.78 | 17.35 | 19.79 | 11.75 | 15.63 | 18.99 | 18.21 | 17.56 | 20.36 |
| Total Return (%) | 53.40 | 9.26 | 5.34 | 17.38 | 14.06 | -40.62 | 33.02 | 21.49 | -0.95 | 9.67 | 11.21 |
| Annual Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Relative Performance | |||||||||||
| Rel Performance-S&P500(%) | 247.14 | -16.05 | 4.55 | 15.93 | 85.68 | -36.19 | 66.01 | 64.34 | -30.50 | -63.16 | -15.24 |
| Rel Performance-Obj.Ret.(%) | 108.18 | -64.19 | -10.27 | 42.95 | 113.92 | -26.96 | 2.83 | -33.72 | 32.91 | -45.05 | 1.33 |
| Ret.Quintile vs Obj(1 is best) | 1 | 5 | 4 | 2 | 1 | 4 | 3 | 5 | 2 | 5 | 4 |
| Turnover, Yields, and Gains | |||||||||||
| Fund Assets Net($mil) | 29 | 24 | 16 | 11 | 10 | 4 | 3 | 2 | 2 | 2 | 2 |
| Annual Turnover (%) | 81.00 | 91.00 | 74.00 | 81.00 | 81.00 | 82.00 | 128.00 | 141.00 | 147.00 | 0.00 | |
| Annual Dividend Paid ($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Annual Capital Gains Paid($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 | 2.36 | 0.00 |
CSGBX : Returns Analysis - Trailing Total Return
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | 15 Year | 20 Year | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Return (through 05/13) | -2.25% | 2.46% | 13.38% | 11.21% | 11.40% | 9.04% | 4.08% | 10.17% | 4.02% | NA |
| Ret. Percentile vs. Obj. (1 is best) | 91 | 89 | 76 | 60 | 73 | 76 | 86 | 45 | 88 | NA |
CSGBX : Stock Portfolio Snapshot - 05/13
| Average Price/Earnings | 45.19 |
| Average Price/Book | 4.27 |
| Average EPS Growth | 7.33 |
| Average Market Value | 1,797.00 |
CSGBX : Stock Sector Breakout - 05/13
CSGBX : Top Holdings - 05/13
| Name | Weight | Shares |
|---|---|---|
| EPOCRATES INC | 4.85 | 6,797,907 |
| TIVO | 3.92 | 4,072,856 |
| JAZZ PHARMACEUTICALS | 3.52 | 846,395 |
| EXLSERVICE HOLDINGS | 3.38 | 1,633,010 |
| CBEYOND COMMUNICATIONS | 2.17 | 3,073,073 |
| WARNER CHILCOTT PLC | 2.93 | 3,117,891 |
| GENTIUM SPA | 2.88 | 3,225,558 |
| COSTAR GROUP INC | 2.30 | 329,493 |
| VIROPHARMA INC | 3.28 | 1,848,092 |